Non-Executive Directors' shar

RNS Number : 0619J

Deltex Medical Group PLC

24 March 2010

 



 

 

Deltex Medical Group plc

Non-Executive Directors' Shareholdings

24 March 2010

Deltex Medical Group plc ("Deltex Medical" or the "Company"), the global leader in oesophageal Doppler monitoring ("ODM"), announces that it has today issued a total of 183,861 new ordinary shares of 1p each in the Company ("New Ordinary Shares") to non-executive directors of the Company at a price of 13.00 pence per share.

The four non-executive directors named below have elected to take shares in lieu of a cash payment as remuneration for their services to the Company for the period 1 January 2010 to 31 March 2010.

In addition to the above, the Company also announces that it has today issued a total of 118,974 New Ordinary Shares to a certain adviser of the Company at a price of 13.00 pence per share.

Accordingly, application has been made for these shares to be admitted to trading on AIM.  The shares rank pari passu with the existing issued shares of the Company and dealings are expected to commence on Monday 29 March 2010.  Following the issue of these new shares the Company has a total of 127,217,171 ordinary shares of 1p each in issue.

Following this issue, the directors' beneficial interests are as follows:

Name of Director	Number of New Ordinary Shares issued in lieu of fees	Holding of shares following issue of New Ordinary Shares	% of enlarged issued share capital
Nigel Keen	64,102	5,471,129	4.30
Dr Edwin Snape (1)	46,154	4,275,597	3.36
Sir Duncan Nichol	36,923	531,831	0.42
Julian Cazalet	36,682	3,362,298	2.64

(1)     Includes shares held as a principal of Nexus Medical Partners II, L.P.

For further information, please contact:-

Deltex Medical Group plc                                                                                01243 774 837
Nigel Keen, Chairman                                        
Ewan Phillips, Chief Executive                           
Paul Mitchell, Finance Director               

Nominated Adviser and Broker                                                                        0207 614 5917

Arden Partners plc 

Christopher Hardie

Matthew Armitt

 

END

 

 

RDSBRGDXIUDBGGX